Cargando…
Delivery of Doxorubicin for Human Cervical Carcinoma Targeting Therapy by Folic Acid-Modified Selenium Nanoparticles
Cancer-specific drug delivery represents an attractive approach to preventing undesirable side effects and increasing the accumulation of the drug in tumors. The surface modification of selenium nanoparticles (SeNPs) with targeting moieties thus represents an effective strategy for cancer therapy. I...
Autores principales: | Xia, Yu, Xu, Tiantian, Zhao, Mingqi, Hua, Liang, Chen, Yi, Wang, Changbing, Tang, Ying, Zhu, Bing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6274826/ https://www.ncbi.nlm.nih.gov/pubmed/30428576 http://dx.doi.org/10.3390/ijms19113582 |
Ejemplares similares
-
Galactose-modified selenium nanoparticles for targeted delivery of doxorubicin to hepatocellular carcinoma
por: Xia, Yu, et al.
Publicado: (2019) -
Functionalized selenium nanoparticles for targeted delivery of doxorubicin to improve non-small-cell lung cancer therapy
por: Xia, Yu, et al.
Publicado: (2018) -
siRNA-loaded selenium nanoparticle modified with hyaluronic acid for enhanced hepatocellular carcinoma therapy
por: Xia, Yu, et al.
Publicado: (2018) -
Novel functionalized nanoparticles for tumor-targeting co-delivery of doxorubicin and siRNA to enhance cancer therapy
por: Xia, Yu, et al.
Publicado: (2017) -
Folate-targeted selenium nanoparticles deliver therapeutic siRNA to improve hepatocellular carcinoma therapy
por: Xia, Yu, et al.
Publicado: (2018)